Medicare Advantage
The CMS on April 6 finalized a rule that will update the Medicare Advantage and Part D prescription drug programs for contract year 2019.
The Centers for Medicare & Medicaid Services late this afternoon released a final rule that makes programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019.
AHA's comment on CMS's 2019 Advance Notice and draft Call Letter for 2019.
AHA Special Bulletin: White House Releases FY 2019 Budget Request with Medicare, Medicaid Reductions
President Trump today submitted to Congress his budget request for fiscal year (FY) 2019.
The AHA generally supports the Centers for Medicare & Medicaid Services’ proposals to increase flexibility in plan design, cost sharing and enrollment for the Medicare Advantage and prescription drug programs in 2019, but recommends caution to ensure that the added flexibility provides value…
AHA comments on the Centers for Medicare & Medicaid Services’ proposed rule outlining 2019 contract year policy and technical changes to the Medicare Advantage and Medicare Prescription Drug Benefit programs.
The Centers for Medicare & Medicaid Services last week announced proposed changes to the risk adjustment model for aged and disabled beneficiaries enrolled in Medicare Advantage Part C plans beginning in calendar year 2019, as required by the 21st Century Cures Act. CMS proposes phasing in the…
The Centers for Medicare & Medicaid Services today announced refinements to the Medicare Advantage Valued-Based Insurance Design Model for calendar year 2019, the third year of the demonstration program. The model is designed to test whether giving MA plans flexibility to offer…
The CMS on Nov. 16 issued a proposed rule that would update Medicare Advantage and the Part D prescription drug program.